Yield Theory
Subscribe

David Taylor · VRTX

David Taylor's VRTX trades

Every Vertex Pharmaceuticals Incorporated transaction David Taylor reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
3
Buys / sells
1 / 2
Disclosed range
$3K – $45K
Last filed
2026-09-05

VRTX transactions reported by David Taylor

3 of 3 rows
TypeOwner
Vertex Pharmaceuticals Incorporated - Common Stock
VRTX		SaleSelf$1,001 - $15,0002026-09-05
#20035392
Vertex Pharmaceuticals Incorporated - Common Stock
VRTX		SaleSelf$1,001 - $15,0002026-02-02
#20033916
Vertex Pharmaceuticals Incorporated - Common Stock
VRTX		PurchaseSelf$1,001 - $15,0002025-09-02
#20030782

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Other House members who reported VRTX

Jefferson Shreve3 VRTX rowsLisa McClain3 VRTX rows

More tickers reported by David Taylor

IBP · Installed Building Products, Inc. Common Stock15 rowsPG · The Procter & Gamble Company13 rowsLRCX · Lam Research Corporation13 rowsMSFT · Microsoft Corporation12 rowsGOOGL · Alphabet Inc.12 rowsAVGO · Broadcom Inc.11 rows

Go deeper

David Taylor: all disclosed tradesTotals, most-traded tickers, filing lagVRTX: every House filerAll verified rows across membersVertex Pharmaceuticals Incorporated researchAudited financials and what moves the stock

David Taylor and VRTX — questions

Did David Taylor buy or sell VRTX?

House Clerk filings for 2025 and 2026 show 1 purchase and 2 sales of Vertex Pharmaceuticals Incorporated (VRTX) reported by David Taylor, between 2025-08-07 and 2026-08-26. Reported owner: Self.

How much VRTX did David Taylor trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $3K – $45K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last VRTX filing by David Taylor?

The most recent periodic transaction report containing a VRTX row was filed on 2026-09-05. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Vertex Pharmaceuticals Incorporated. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

David Taylor VRTX disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

Get this month’s call for $15

$15/mo or $150/yr · cancel future renewals anytime · sources included